Neuroprotective strategies of cerebrolysin for the treatment of infants with neonatal hypoxic-ischemic encephalopathy.
Brian FianiDaniel ChaconRyan JarrahMichaela BarthelmassClaudia CovarrubiasPublished in: Acta neurologica Belgica (2021)
Our literature search emphasizes the positive effects of cerebrolysin for general improvement outcomes. Nevertheless, biomarker establishment is warranted to improve patient outcomes.